Merck & Co Launches New Hepatitis C Drug

BMI View: Mexico's pharmaceutical market has many fundamental characteristics that are attracting drugmakers, including relatively high urbanisation, a significant chronic disease burden and established health insurance programmes. However, pharmaceutical companies have to be cautious of the country's political and economic issues.

To read the full article, please choose one of the following options: